US Map / Vermont
State VT

Clinical Trials in Vermont

Recruiting clinical trials with at least one study location in Vermont. Data updated daily from ClinicalTrials.gov.

Total Trials
35
Recruiting Now
35
← Back to US Map
Top Conditions in Vermont
Oral Cavity Squamous Cell Carcinoma (2)Stage I Lip and Oral Cavity Cancer AJCC v8 (2)Stage II Lip and Oral Cavity Cancer AJCC v8 (2)Cystic Fibrosis (2)Clinical Stage I HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Clinical Stage III HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8 (1)Head and Neck Squamous Cell Carcinoma (1)Hypopharyngeal Squamous Cell Carcinoma (1)Laryngeal Squamous Cell Carcinoma (1)Nasopharyngeal Squamous Cell Carcinoma (1)Oropharyngeal Squamous Cell Carcinoma (1)

Frequently Asked Questions — Clinical Trials in Vermont

How many clinical trials are currently recruiting in Vermont?
ClinicalMetric currently tracks 35 actively recruiting clinical trials with at least one location in Vermont. The total number of registered studies—including active but not currently enrolling trials—is 35. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Vermont?
Vermont hosts clinical trials across a broad range of medical conditions, including Oral Cavity Squamous Cell Carcinoma, Stage I Lip and Oral Cavity Cancer AJCC v8, Stage II Lip and Oral Cavity Cancer AJCC v8, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Vermont serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Vermont?
To join a clinical trial in Vermont, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Vermont maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Vermont

NCT06191640 N/A
Recruiting
Sinus Disease in Young Children With Cystic Fibrosis
Condition
Cystic Fibrosis in Children
Enrollment
80 pts
Location
United States
Sponsor
University of California, Los
View Trial →
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States
Sponsor
NRG Oncology
View Trial →
NCT04852887 Phase 3
Recruiting
De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, O...
Condition
Stage I Breast Cancer
Enrollment
1,670 pts
Location
United States, Canada, Hong Kong
Sponsor
NRG Oncology
View Trial →
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
View Trial →
NCT06876714 Phase 3
Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People W...
Condition
Anatomic Stage I Breast Cancer AJCC v8
Enrollment
1,524 pts
Location
United States, Puerto Rico
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT05265520 N/A
Recruiting
His-Bundle Corrective Pacing in Heart Failure
Condition
Right Bundle-Branch Block
Enrollment
120 pts
Location
United States
Sponsor
University of Rochester
View Trial →
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
View Trial →
NCT05987241 Phase 2, Phase 3
Recruiting
Testing the Role of DNA Released From Tumor Cells Into the Blood in Guiding the ...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
992 pts
Location
United States, Canada
Sponsor
National Cancer Institute (NCI
View Trial →
NCT02523014 Phase 2
Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating ...
Condition
Intracranial Meningioma
Enrollment
124 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
View Trial →
NCT06401330 Phase 3
Recruiting
A Study Using Risk Factors to Determine Treatment for Children With Favorable Hi...
Condition
Stage I Mixed Cell Type Kidney Wilms Tumor
Enrollment
1,656 pts
Location
United States, Australia, Canada
Sponsor
Children's Oncology Group
View Trial →
Page 2 of 2 — 35 trials total
← Prev
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology